Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (374)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
293
5.570
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
2025
89
1.630
Why?
Antineoplastic Combined Chemotherapy Protocols
18
2026
1961
1.230
Why?
Down Syndrome
6
2023
522
1.220
Why?
Burkitt Lymphoma
3
2024
62
0.920
Why?
Leukemia, Myeloid, Acute
7
2026
685
0.870
Why?
Asparaginase
8
2020
30
0.830
Why?
Fishes
1
2024
110
0.800
Why?
Agriculture
1
2024
103
0.780
Why?
Child
74
2026
22600
0.730
Why?
Bayes Theorem
1
2024
426
0.720
Why?
Consolidation Chemotherapy
2
2019
11
0.650
Why?
Neoplasm Recurrence, Local
6
2025
1145
0.610
Why?
Child, Preschool
49
2026
11790
0.600
Why?
Ecosystem
1
2024
591
0.580
Why?
Disease-Free Survival
12
2024
768
0.540
Why?
Leukemia
4
2021
245
0.540
Why?
Oncogene Proteins, Fusion
6
2024
211
0.530
Why?
Mercaptopurine
5
2017
15
0.500
Why?
Prognosis
17
2026
4312
0.500
Why?
Infant
36
2026
10023
0.460
Why?
Antineoplastic Agents
7
2019
2201
0.450
Why?
Recurrence
12
2025
1136
0.450
Why?
Preleukemia
1
2015
2
0.440
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
127
0.440
Why?
Drug Hypersensitivity
3
2017
89
0.430
Why?
Molecular Targeted Therapy
3
2021
437
0.420
Why?
Leukemia, Monocytic, Acute
1
2014
3
0.420
Why?
Sarcoma, Myeloid
1
2014
4
0.420
Why?
Neoplasm, Residual
7
2023
139
0.400
Why?
Adolescent
42
2026
22409
0.400
Why?
Bone Marrow Transplantation
1
2014
293
0.380
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
26
0.360
Why?
Erwinia
2
2020
3
0.350
Why?
Medical Oncology
5
2025
331
0.350
Why?
Tumor Suppressor Proteins
3
1999
319
0.350
Why?
Humans
86
2026
144671
0.350
Why?
Chromosome Aberrations
2
2022
164
0.340
Why?
Acute Kidney Injury
1
2019
869
0.340
Why?
Neutropenia
2
2022
155
0.330
Why?
Male
58
2026
72431
0.330
Why?
Hematopoietic Stem Cell Transplantation
2
2019
677
0.330
Why?
Stem Cell Transplantation
3
2019
190
0.320
Why?
Rhabdomyosarcoma
1
2011
64
0.320
Why?
Cell Cycle Proteins
3
1999
628
0.310
Why?
Carrier Proteins
3
1999
733
0.310
Why?
Sarcoma, Ewing
1
2011
103
0.300
Why?
Biomarkers, Tumor
3
2026
1319
0.300
Why?
Ploidies
2
2019
20
0.300
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
192
0.290
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
30
0.280
Why?
Genes, Tumor Suppressor
2
1999
85
0.280
Why?
Catheter-Related Infections
2
2022
95
0.280
Why?
Survival Rate
8
2024
2089
0.280
Why?
Cyclophosphamide
4
2019
265
0.280
Why?
Female
56
2026
78304
0.270
Why?
Catheterization, Central Venous
2
2022
124
0.260
Why?
Philadelphia Chromosome
2
2018
18
0.260
Why?
Medication Adherence
3
2017
540
0.250
Why?
Gene Deletion
2
1998
392
0.240
Why?
Vincristine
4
2021
140
0.230
Why?
Neoplasm Proteins
2
2018
441
0.230
Why?
Trisomy
2
2021
78
0.230
Why?
Antimetabolites, Antineoplastic
2
2017
105
0.230
Why?
Etoposide
2
2019
168
0.230
Why?
Ikaros Transcription Factor
1
2025
23
0.220
Why?
Young Adult
15
2024
14122
0.210
Why?
Maryland
1
2024
67
0.210
Why?
Invertebrates
1
2024
24
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
72
0.210
Why?
Rivers
1
2024
68
0.200
Why?
Treatment Outcome
12
2023
11735
0.200
Why?
PAX5 Transcription Factor
2
2024
14
0.200
Why?
Anxiety
3
2016
1122
0.200
Why?
Polymorphism, Single Nucleotide
4
2025
2137
0.190
Why?
Genomics
4
2025
831
0.190
Why?
Gene Rearrangement
3
2019
155
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
76
0.180
Why?
Polyethylene Glycols
5
2020
653
0.180
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
4
0.180
Why?
Induction Chemotherapy
2
2019
87
0.180
Why?
Central Venous Catheters
1
2022
52
0.170
Why?
Health Equity
1
2024
132
0.170
Why?
Environmental Monitoring
1
2024
374
0.170
Why?
Program Evaluation
2
2017
941
0.170
Why?
Prednisone
2
2019
221
0.170
Why?
Lymphoma
1
2023
233
0.170
Why?
Doxorubicin
2
2022
398
0.160
Why?
Lung Neoplasms
1
2014
2660
0.160
Why?
Adult
23
2023
40489
0.160
Why?
Translocation, Genetic
2
2013
118
0.160
Why?
Maintenance Chemotherapy
2
2017
42
0.150
Why?
Bacterial Infections
1
2022
247
0.150
Why?
Immunocompromised Host
1
2021
202
0.150
Why?
Diploidy
1
2019
16
0.150
Why?
Risk Factors
11
2022
10796
0.150
Why?
Genes, p16
1
1999
13
0.150
Why?
Hyperglycemia
1
2023
374
0.140
Why?
Chromosomes, Human, Pair 19
1
1998
26
0.140
Why?
Quality of Life
3
2024
3183
0.140
Why?
Chromosomes, Human, Pair 17
1
1998
53
0.140
Why?
Myelodysplastic Syndromes
1
2020
147
0.140
Why?
Antibodies, Bispecific
1
2019
69
0.140
Why?
Rituximab
1
2019
211
0.140
Why?
Prospective Studies
9
2022
7994
0.140
Why?
Chromosomes, Human, Pair 1
1
1998
79
0.140
Why?
Mutagenesis
1
1999
194
0.140
Why?
Prostate-Specific Antigen
2
2009
162
0.130
Why?
Substance Withdrawal Syndrome
1
2020
187
0.130
Why?
Proto-Oncogenes
1
1997
28
0.130
Why?
Patient Safety
1
2021
353
0.130
Why?
Family Relations
2
2016
88
0.130
Why?
Thioguanine
1
2017
18
0.130
Why?
Thionucleotides
1
2017
35
0.130
Why?
Apyrase
1
2017
26
0.130
Why?
Oncologists
1
2017
46
0.130
Why?
Blast Crisis
1
2016
34
0.120
Why?
Carboxypeptidases A
1
2016
2
0.120
Why?
Follow-Up Studies
6
2021
5414
0.120
Why?
Pediatricians
1
2017
121
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
268
0.120
Why?
Adrenal Cortex Hormones
1
2019
480
0.120
Why?
Sepsis
1
2022
643
0.120
Why?
Osteonecrosis
1
2015
23
0.110
Why?
Nausea
1
2016
112
0.110
Why?
Retrospective Studies
10
2023
17149
0.110
Why?
Mentors
2
2017
214
0.110
Why?
Cohort Studies
6
2026
5957
0.110
Why?
Depression
2
2016
1561
0.110
Why?
Pancreatitis
1
2016
145
0.110
Why?
Central Nervous System Neoplasms
1
2017
175
0.110
Why?
Dexamethasone
4
2021
366
0.110
Why?
Monitoring, Physiologic
1
2017
288
0.110
Why?
Fusion Proteins, bcr-abl
2
2016
68
0.110
Why?
Mutation
4
2022
4081
0.110
Why?
Longitudinal Studies
7
2016
2942
0.110
Why?
Mentoring
1
2017
164
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.110
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
72
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2017
552
0.100
Why?
Flow Cytometry
1
2018
1154
0.100
Why?
Bacteremia
1
2016
222
0.100
Why?
Repressor Proteins
1
1997
428
0.100
Why?
Antigens, CD
1
2017
552
0.100
Why?
Cross Infection
1
2016
263
0.100
Why?
Life Change Events
1
2014
147
0.100
Why?
Chromosomes, Human, Pair 21
1
2013
42
0.100
Why?
DNA-Binding Proteins
2
1998
1484
0.100
Why?
Histone-Lysine N-Methyltransferase
2
2010
141
0.100
Why?
Pediatrics
3
2021
1121
0.100
Why?
Immunotherapy
1
2018
662
0.100
Why?
Risk Assessment
5
2026
3729
0.090
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.090
Why?
Venous Thromboembolism
1
2017
326
0.090
Why?
Transcription Factors
2
1998
1726
0.090
Why?
Myeloproliferative Disorders
1
2012
20
0.090
Why?
Karyotyping
3
2019
105
0.090
Why?
Quality Improvement
1
2021
1287
0.090
Why?
Self Report
1
2017
869
0.090
Why?
Contraindications
1
2012
90
0.090
Why?
Arabinonucleosides
1
2011
8
0.090
Why?
Adenine Nucleotides
1
2011
21
0.090
Why?
Prostatic Neoplasms
2
2009
978
0.080
Why?
Antibodies, Monoclonal
1
2018
1505
0.080
Why?
Chromosomes, Human, Pair 4
1
2010
25
0.080
Why?
Chromosomes, Human, Pair 10
1
2010
19
0.080
Why?
Pain
1
2016
785
0.080
Why?
Multivariate Analysis
4
2015
1537
0.080
Why?
T-Lymphocytes
1
2018
1984
0.080
Why?
Parents
2
2016
1395
0.070
Why?
Prostatectomy
1
2009
94
0.070
Why?
Age Factors
8
2019
3329
0.070
Why?
Bloom Syndrome
1
1988
3
0.070
Why?
Neoplasm Metastasis
1
2011
691
0.070
Why?
Juxtaglomerular Apparatus
1
2007
2
0.070
Why?
Gene Expression Regulation, Leukemic
2
2016
56
0.070
Why?
Polymerase Chain Reaction
1
2010
1047
0.060
Why?
Drug Administration Schedule
2
2017
779
0.060
Why?
Blood Coagulation
1
2008
269
0.060
Why?
Clinical Trials, Phase III as Topic
1
2026
116
0.060
Why?
Stress, Psychological
1
2014
1148
0.060
Why?
Clinical Trials as Topic
2
2024
1056
0.060
Why?
Surveys and Questionnaires
4
2024
6041
0.060
Why?
Animals
3
2024
37948
0.060
Why?
Methotrexate
2
2017
231
0.060
Why?
Remission Induction
2
2019
309
0.050
Why?
Case-Control Studies
3
2024
3603
0.050
Why?
Acute Disease
2
2019
1029
0.050
Why?
Selection Bias
1
2024
38
0.050
Why?
Personal Satisfaction
2
2017
220
0.050
Why?
Incidence
3
2019
2892
0.050
Why?
Administration, Oral
2
2017
851
0.050
Why?
Genetic Variation
1
1988
985
0.050
Why?
Kidney Neoplasms
1
2007
412
0.050
Why?
Drug Monitoring
2
2017
396
0.050
Why?
Risk
5
2023
911
0.050
Why?
Disease Progression
2
2021
2847
0.040
Why?
Proto-Oncogene Proteins c-cbl
1
2022
13
0.040
Why?
Randomized Controlled Trials as Topic
2
2020
1742
0.040
Why?
Exome
1
2022
227
0.040
Why?
Drug Therapy
1
2021
80
0.040
Why?
Menorrhagia
1
2001
22
0.040
Why?
Transcriptome
2
2019
1036
0.040
Why?
Diarrhea
2
1999
192
0.040
Why?
Bone Marrow
1
2022
306
0.040
Why?
Endocrine Glands
1
1979
14
0.040
Why?
Blood Cell Count
1
1999
55
0.040
Why?
Chromosomes, Human
1
2019
41
0.040
Why?
Genome-Wide Association Study
2
2016
1374
0.040
Why?
Cytogenetic Analysis
1
2019
33
0.040
Why?
Azacitidine
1
2020
157
0.040
Why?
Loss of Heterozygosity
1
1999
52
0.040
Why?
Viral Load
1
2021
528
0.040
Why?
Mosaicism
1
2019
73
0.040
Why?
Sequence Deletion
1
1999
191
0.040
Why?
Hypertension
1
2007
1262
0.040
Why?
National Cancer Institute (U.S.)
1
2018
52
0.030
Why?
Disinfectants
1
1999
49
0.030
Why?
Chromosomes
1
2019
108
0.030
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
279
0.030
Why?
Escherichia coli O157
1
1998
36
0.030
Why?
Infant, Newborn
4
2019
6399
0.030
Why?
Methylation
1
1998
241
0.030
Why?
Overweight
1
2023
606
0.030
Why?
Community Participation
1
1999
122
0.030
Why?
Biopsy
1
2021
1079
0.030
Why?
Genetic Predisposition to Disease
2
2017
2350
0.030
Why?
Interviews as Topic
1
2021
905
0.030
Why?
Erythrocyte Count
1
2017
21
0.030
Why?
United States
4
2021
16018
0.030
Why?
Glucose
1
2023
1033
0.030
Why?
Public Health Surveillance
1
2017
83
0.030
Why?
Escherichia coli Infections
1
1998
126
0.030
Why?
Food-Drug Interactions
1
2017
11
0.030
Why?
Proto-Oncogene Proteins c-ets
1
1997
56
0.030
Why?
Injections, Intramuscular
1
2017
144
0.030
Why?
Career Mobility
1
2017
70
0.030
Why?
Leucovorin
1
2017
100
0.030
Why?
Dairy Products
1
2017
30
0.030
Why?
Cerebrospinal Fluid
1
2017
88
0.030
Why?
MEF2 Transcription Factors
1
2016
51
0.030
Why?
Cranial Irradiation
1
2017
85
0.030
Why?
Water Purification
1
1999
157
0.030
Why?
Family
1
2021
685
0.030
Why?
Infusions, Intravenous
1
2017
422
0.030
Why?
Leukocyte Count
1
2017
315
0.030
Why?
Luciferases
1
2016
152
0.030
Why?
NIH 3T3 Cells
1
2016
147
0.030
Why?
Methyltransferases
1
2017
75
0.030
Why?
Feasibility Studies
1
2021
1103
0.030
Why?
Sulfonamides
1
2020
579
0.030
Why?
Ethers
1
1996
18
0.030
Why?
Methyl Ethers
1
1996
19
0.030
Why?
Bone Morphogenetic Protein 7
1
2015
12
0.030
Why?
Fluorides
1
1996
49
0.030
Why?
Hemorrhage
1
2001
813
0.030
Why?
Cytarabine
1
2016
66
0.030
Why?
Health Education
1
1999
345
0.030
Why?
Genotype
3
2017
1847
0.030
Why?
Anesthetics, Inhalation
1
1996
52
0.030
Why?
Breast Neoplasms
5
1979
2365
0.030
Why?
Severity of Illness Index
2
2017
2922
0.030
Why?
Spinal Dysraphism
1
1996
110
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
218
0.030
Why?
Disease Management
1
2019
650
0.030
Why?
Middle Aged
10
2019
35971
0.030
Why?
Alternative Splicing
1
2017
247
0.030
Why?
Homeodomain Proteins
1
1998
523
0.030
Why?
HEK293 Cells
1
2017
743
0.030
Why?
Promoter Regions, Genetic
1
1999
1246
0.030
Why?
Sequence Analysis, RNA
1
2016
442
0.030
Why?
Intensive Care Units, Pediatric
1
2016
288
0.030
Why?
DNA Methylation
1
1999
664
0.030
Why?
Qualitative Research
1
2021
1668
0.020
Why?
Behavior
1
2014
90
0.020
Why?
Psychomotor Agitation
1
2014
70
0.020
Why?
Demography
1
2014
287
0.020
Why?
Income
1
2014
201
0.020
Why?
Marriage
1
2014
122
0.020
Why?
Algorithms
1
2021
1844
0.020
Why?
Base Sequence
1
2016
2177
0.020
Why?
Aged
9
2019
25955
0.020
Why?
Blood Glucose
1
2023
2326
0.020
Why?
Odds Ratio
1
2015
1076
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
323
0.020
Why?
Aggression
1
2014
178
0.020
Why?
Prevalence
2
2016
2839
0.020
Why?
Nucleoside Transport Proteins
1
2011
8
0.020
Why?
Kidney
2
1996
1495
0.020
Why?
Regression Analysis
1
2014
998
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
72
0.020
Why?
Time Factors
2
2015
7140
0.020
Why?
Erythrocytes
1
2017
750
0.020
Why?
Escherichia coli
1
2015
854
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
176
0.020
Why?
Mice
2
2019
18261
0.020
Why?
Survival Analysis
1
2013
1370
0.020
Why?
Logistic Models
1
2015
2114
0.020
Why?
Bacteria
1
2016
894
0.020
Why?
Obesity
1
2023
3070
0.020
Why?
Kaplan-Meier Estimate
1
2011
967
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Cell Fusion
1
1988
48
0.020
Why?
Genetic Complementation Test
1
1988
72
0.020
Why?
Emotions
1
2014
578
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
85
0.020
Why?
Protein C
1
2008
53
0.020
Why?
Water Microbiology
2
1999
93
0.020
Why?
Antithrombins
1
2008
69
0.020
Why?
Mice, Inbred C57BL
1
2019
5967
0.020
Why?
Genetic Markers
1
1988
332
0.020
Why?
Fibrinogen
1
2008
181
0.020
Why?
Renin-Angiotensin System
1
2007
79
0.020
Why?
Transplantation, Homologous
1
2008
407
0.020
Why?
Biopsy, Needle
1
2007
184
0.020
Why?
Rare Diseases
1
2007
115
0.020
Why?
Blood Pressure Determination
1
2007
143
0.020
Why?
Nephrectomy
1
2007
158
0.020
Why?
Biomarkers
1
2017
4261
0.010
Why?
RNA, Messenger
1
2011
2815
0.010
Why?
Immunohistochemistry
1
2007
1705
0.010
Why?
Cell Line
1
1988
2821
0.010
Why?
Anemia, Hypochromic
1
2001
2
0.010
Why?
Blood Platelet Disorders
1
2001
10
0.010
Why?
von Willebrand Diseases
1
2001
28
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Estrone
1
1979
40
0.010
Why?
Menstruation
1
1979
40
0.010
Why?
Prolactin
1
1979
87
0.010
Why?
Thrombocytopenia
1
2001
202
0.010
Why?
Bolivia
1
1999
61
0.010
Why?
Luteinizing Hormone
1
1979
190
0.010
Why?
Progesterone
1
1979
209
0.010
Why?
Follicle Stimulating Hormone
1
1979
249
0.010
Why?
Restaurants
1
1998
22
0.010
Why?
Swimming
1
1998
53
0.010
Why?
Food Handling
1
1998
63
0.010
Why?
Disease Transmission, Infectious
1
1998
68
0.010
Why?
Water Supply
1
1998
90
0.010
Why?
Meat
1
1998
93
0.010
Why?
Kyphosis
1
1996
37
0.010
Why?
Halothane
1
1996
8
0.010
Why?
Analysis of Variance
1
1999
1301
0.010
Why?
Estradiol
1
1979
507
0.010
Why?
Congenital Abnormalities
1
1996
104
0.010
Why?
Population Surveillance
1
1999
484
0.010
Why?
Feces
1
1998
513
0.010
Why?
Diagnostic Imaging
1
1996
341
0.010
Why?
Ovarian Neoplasms
1
1978
589
0.010
Why?
Pedigree
3
1978
515
0.010
Why?
Nebraska
2
1976
21
0.000
Why?
Aged, 80 and over
1
1999
8284
0.000
Why?
New York
2
1976
127
0.000
Why?
Genes
1
1978
226
0.000
Why?
Genetic Linkage
1
1978
273
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
67
0.000
Why?
Pheochromocytoma
1
1976
67
0.000
Why?
Statistics as Topic
1
1976
284
0.000
Why?
Syndrome
1
1976
379
0.000
Why?
Klinefelter Syndrome
1
1976
69
0.000
Why?
HLA Antigens
1
1976
235
0.000
Why?
Abnormalities, Multiple
1
1976
197
0.000
Why?
Skin Diseases
1
1976
151
0.000
Why?
Pregnancy
2
1978
7122
0.000
Why?
Sarcoma
1
1976
203
0.000
Why?
Sex Factors
1
1978
2104
0.000
Why?
Thyroid Neoplasms
1
1976
349
0.000
Why?
Neoplasms
2
1976
2873
0.000
Why?
Melanoma
1
1976
757
0.000
Why?
Phenotype
1
1976
3147
0.000
Why?
Registries
1
1976
2392
0.000
Why?
Brain Neoplasms
1
1976
1327
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)